FDA Inspection 1155218 — Arbor Pharmaceuticals Inc.

Arbor Pharmaceuticals Inc. — FEI 3006411608

The FDA completed an inspection of Arbor Pharmaceuticals Inc. on Oct 15, 2021 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 15, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Atlanta, GA (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.